In patients with prosthetic valve endocarditis (PVE) and pathological valvular FDG uptake on the initial FDG-PET and not referred to valve replacement at the acute phase, the study will assess whether FDG-PET is able to identify those at increased risk of PVE relapse.
Patient aged 18 or over;
Have a prosthetic valve implanted surgically or by catheter for at least 3 months;
Presenting a definite IE on a prosthetic valve (ESC definition in force);
Having benefited from an FDG-PET examination for diagnostic purposes as part of the treatment revealing pathological hyperuptake at the level of the prosthetic valve AND carried out <15 days after the start of antibiotic therapy for infective endocarditis;
Patient under legal protection, guardianship or curators;
Pregnancy, breastfeeding;
Patient not affiliated to a health insurance scheme or not a beneficiary of a social security scheme;
Simultaneous participation in a study on FDG-PET;